Gal Cohen
Director/Board Member bei SILVER CASTLE HOLDINGS LTD
Profil
Gal Cohen is currently the Chief Executive Officer & Director at Quark Pharmaceuticals, Inc. He is also the Executive Chairman at Ayana Pharma Ltd., the Independent External Director at Silver Castle Holdings Ltd., and the Director at BioLineRx Ltd.
Previously, he served as the President & Chief Executive Officer at MediWound Ltd.
from 2014 to 2019.
He also worked as the Director of Strategic Business Planning at Teva Pharmaceutical Industries Ltd.
and Teva Pharmaceuticals Ltd.
(Israel) from 2004 to 2006.
Mr. Cohen holds an MBA from Tel-Aviv University and an undergraduate degree from Technion-Israel Institute of Technology.
Aktive Positionen von Gal Cohen
| Unternehmen | Position | Beginn |
|---|---|---|
| SILVER CASTLE HOLDINGS LTD | Director/Board Member | 03.04.2022 |
| BIOLINERX LTD. | Director/Board Member | 01.01.2023 |
Ayana Pharma Ltd.
 Ayana Pharma Ltd. Pharmaceuticals: MajorHealth Technology Ayana Pharma Ltd. is an Israeli pharmaceutical company that specializes in developing liposomal therapeutics for cancer treatment. The company is based in Jerusalem, Israel. Ayana Pharma was founded in 2012 by Yechezkel Barenholz and Avraham Molcho, with Yechezkel Barenholz serving as the CEO since its inception. | Chairman | 01.11.2019 |
Quark Pharmaceuticals, Inc.
 Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Chief Executive Officer | 01.04.2020 |
Ehemalige bekannte Positionen von Gal Cohen
| Unternehmen | Position | Ende |
|---|---|---|
| MEDIWOUND LTD. | Chief Executive Officer | 31.05.2019 |
| Teva Pharmaceuticals Ltd. (Israel) | Corporate Officer/Principal | 01.01.2006 |
Ausbildung von Gal Cohen
| Tel-Aviv University | Masters Business Admin |
| Technion-Israel Institute of Technology | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| BIOLINERX LTD. | Health Technology |
| MEDIWOUND LTD. | Health Technology |
| SILVER CASTLE HOLDINGS LTD | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Quark Pharmaceuticals, Inc.
Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Health Technology |
Ayana Pharma Ltd.
Ayana Pharma Ltd. Pharmaceuticals: MajorHealth Technology Ayana Pharma Ltd. is an Israeli pharmaceutical company that specializes in developing liposomal therapeutics for cancer treatment. The company is based in Jerusalem, Israel. Ayana Pharma was founded in 2012 by Yechezkel Barenholz and Avraham Molcho, with Yechezkel Barenholz serving as the CEO since its inception. | Health Technology |
| Teva Pharmaceuticals Ltd. (Israel) |
